Burkholderia pseudomallei 668

Burkholderia_pseudomallei
Names Burkholderia pseudomallei 668
Accession numbers NC_009074, NC_009075
Background Burkholderia pseudomallei is an opportunistic pathogen and a common cause of human pneumonia and fatal bacteremias in endemic areas. Clinical manifestations of B. pseudomallei infection, a disease known as melioidosis, vary greatly from an asymptomatic state, to benign pneumonitis, to acute or chronic pneumonia, or to overwhelming septicemia. Treatment of melioidosis can involve up to nine months of antibiotic therapy, and relapse of the disease is common. The latency period of the organism may vary from two days to 26 years. It is endemic in Southeast Asia and northern Australia, but has also been found in Africa, the Middle East, Europe, Central and South America. Besides humans, melioidosis can affect animals such as sheep, goats, horses, swine, dogs and cats. Transmission occurs by contact with contaminated soil and water, through skin abrasions or inhalation of dust. In northeastern Thailand, B.pseudomallei accounts for 20% of bacterial septicaemias (adapted from http://www.cdc.gov/ncidod/dbmd/diseaseinfo/melioidosis_g.htm). Strain 668 will be used for comparative genomics. (EBI Integr8)
Taxonomy
Kingdom:Bacteria
Phylum:Proteobacteria
Class:Betaproteobacteria
Order:Burkholderiales
Family:Burkholderiaceae
Genus:Burkholderia
Species:pseudomallei
Strain 668
Complete Yes
Sequencing centre (01-MAR-2007) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
(13-FEB-2007) The Institute for Genomic Research, 9712 Medical Center Dr, Rockville, MD 20850, USA
Sequencing quality Level 6: Finished
Sequencing depth NA
Sequencing method NA
Isolation site NA
Isolation country NA
Number of replicons 2
Gram staining properties Negative
Shape Bacilli
Mobility Yes
Flagellar presence Yes
Number of membranes 2
Oxygen requirements Aerobic
Optimal temperature NA
Temperature range Mesophilic
Habitat Terrestrial
Biotic relationship Free living
Host name Homo sapiens
Cell arrangement NA
Sporulation NA
Metabolism NA
Energy source NA
Diseases Melioidosis
Pathogenicity Yes
Glycolysis / Gluconeogenesis
Citrate cycle (TCA cycle)
Pentose phosphate pathway
Fructose and mannose metabolism
Fatty acid metabolism
Synthesis and degradation of ketone bodies
Ubiquinone and other terpenoid-quinone biosynthesis
Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Glycine, serine and threonine metabolism
Cysteine and methionine metabolism
Valine, leucine and isoleucine degradation
Geraniol degradation
Valine, leucine and isoleucine biosynthesis
Lysine biosynthesis
Lysine degradation
Arginine and proline metabolism
Histidine metabolism
Phenylalanine metabolism
Benzoate degradation
Fluorobenzoate degradation
Phenylalanine, tyrosine and tryptophan biosynthesis
beta-Alanine metabolism
Taurine and hypotaurine metabolism
Selenocompound metabolism
Cyanoamino acid metabolism
D-Glutamine and D-glutamate metabolism
D-Arginine and D-ornithine metabolism
D-Alanine metabolism
Glutathione metabolism
Starch and sucrose metabolism
Amino sugar and nucleotide sugar metabolism
Streptomycin biosynthesis
Lipopolysaccharide biosynthesis
Peptidoglycan biosynthesis
Pyruvate metabolism
Toluene degradation
Chloroalkane and chloroalkene degradation
Naphthalene degradation
Glyoxylate and dicarboxylate metabolism
Propanoate metabolism
Ethylbenzene degradation
Styrene degradation
Butanoate metabolism
C5-Branched dibasic acid metabolism
One carbon pool by folate
Thiamine metabolism
Riboflavin metabolism
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Biotin metabolism
Lipoic acid metabolism
Folate biosynthesis
Porphyrin and chlorophyll metabolism
Terpenoid backbone biosynthesis
Nitrogen metabolism
Sulfur metabolism
Caprolactam degradation
Aminoacyl-tRNA biosynthesis
Biosynthesis of unsaturated fatty acids